Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
319
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
-346K
-
Total reported value, excl. options
-
$4.87B
-
Value change
-
-$59.8M
-
Put/Call ratio
-
0.59
-
Number of buys
-
136
-
Number of sells
-
-148
-
Price
-
$176.63
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q2 2021
353 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q2 2021.
Medpace Holdings, Inc. - Common Stock (MEDP) has 319 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
of 28.4M outstanding shares and own 96.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.72M shares), VANGUARD GROUP INC (3.23M shares), WASATCH ADVISORS INC (2.45M shares), Invesco Ltd. (927K shares), STATE STREET CORP (849K shares), PRICE T ROWE ASSOCIATES INC /MD/ (703K shares), DIMENSIONAL FUND ADVISORS LP (642K shares), Pendal Group Ltd (638K shares), Boston Trust Walden Corp (526K shares), and GEODE CAPITAL MANAGEMENT, LLC (521K shares).
This table shows the top 319 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.